By Bowling Green Today |
May 17, 2024
On Wednesday, U.S. Senator Rand Paul (R-KY) and U.S. Congressman Brad Finstad (MN-01) introduced a resolution under the Congressional Review Act (CRA) to repeal a rule recently finalized by the Food and Drug Administration (FDA). The rule, titled "Medical Devices: Laboratory Developed Tests" (LDTs), was published on May 6th and seeks to impose regulations on the creation and implementation of laboratory developed tests (LDTs). These regulations are perceived as burdensome, potentially limiting patients' access to critical diagnostic testing.